Get Our FREE Newsletter

Sign Up

Bull of the Day: Exact Sciences (EXAS)

Spread the love

Exact Sciences EXAS is the $19 billion leader in proactive cancer diagnostics with the Cologuard screening kit, which the majority of healthcare providers are actively prescribing and seeking insurance reimbursement for.This represents a potential $18 billion total addres

This post was originally published on this site